EP0875244A2 — Cosmetically accceptable microstructured compositions
Assigned to Novartis AG · Expires 1998-11-04 · 28y expired
What this patent protects
The present invention provides a microstructured cosmetic composition comprising: A) a cosmetically acceptable oil phase which is dispersed in; B) an aqueous phase comprising 0.05 to 3.0, preferably 0.2 to 1.0 % by weight, based on the weight of the total composition, of a β…
USPTO Abstract
The present invention provides a microstructured cosmetic composition comprising: A) a cosmetically acceptable oil phase which is dispersed in; B) an aqueous phase comprising 0.05 to 3.0, preferably 0.2 to 1.0 % by weight, based on the weight of the total composition, of a β-1,3-glucan having a mean molecular weight within the range of from 1. 10 6 to 12.10 6 , preferably from 2. 10 6 to 10.10 6 ; the oil phase A) in the microstructured cosmetic composition having a mean particle size within the range of from 0.05 to 1000 microns.
Drugs covered by this patent
- Verdeso (DESONIDE) · Padagis Us
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.